Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Older than 18 years~* Scheduled for noncardiac surgery elective low-risk or intermediate~* Expected surgery time greater than 1 hour~* Procedure requiring general anesthesia~* Classification of the American Society of Anesthesiologists (ASA) as I or II~Exclusion Criteria:~* Pregnant women~* Surgery scheduled urgent or emergency~* Personal history of allergy to eggs or any other part of propofol~* Personal history of abnormalities or congenital or acquired cognitive sequels: infantile cerebral palsy, Down syndrome, cerebral ischemic disease, traumatic brain injury, brain tumor, autism.~* Chronic use of benzodiazepines or antipsychotics~* A patient who does not consent to participate in the study prior to surgery or before randomization~* Need for anesthetic or analgesic blockade before surgery peripheral nerve

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Closed-Loop (Type: EXPERIMENTAL): This group includes patients with randomization process be assigned to closed loop intravenous anesthesia; the system evaluates, feeds and acts according to the patient's bispectral index, excluding the anesthesiologist. This system use a variable control of specific therapeutic effect; a target value for this variable (set point); an actuator control (infusion pump), a system (patient) and a control algorithm.
- Open-Loop (Type: ACTIVE_COMPARATOR): This group includes patients with the randomization process are assigned to open loop in which the application of anesthetics is exclusively with pharmacokinetic parameters using TCI and employs mathematical models drug. For propofol used Schneider model and Minto model for remifentanil based on effective site concentration. Changes will be made by the anesthesiologist according to his criteria, trying to keep the BIS range of 40 and 60.

Based on this trial design, predict the completion outcome and termination type (if applicable).